District Of Columbia is currently home to 851 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Washington, Washington, D.C., Washington DC and Washington, Dc. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
Diagnostic Yield of Intranodal Forceps Biopsies in Mediastinal Adenopathy
NCT05374447
Recruiting
The investigators will compare endobronchial ultrasound transbronchial needle aspiration (EBUS-TBNA) with intranodal forceps biopsy (EBUS-IFB) as it relates to the rate of diagnosis of suspected sarcoidosis.
Gender:
ALL
Ages:
Between 18 years and 99 years
Trial Updated:
10/24/2023
Locations: The George Washington University Hospital, Washington, District of Columbia
Conditions: Mediastinal Lymphadenopathy, Sarcoidosis, Pulmonary, Mediastinal Diseases
Register for Updates
The Selfie Study- Assessing Novel Markers for Cervical Cancer Screening From Self-collected Samples
NCT04423679
Recruiting
Cervical cancer is primarily caused by Human Papillomaviruses (HPV). Testing for HPV in cervical samples is now an option for cervical cancer screening. HPV can also be tested from self-collected samples which may help to improve access to screening, since it does not require a doctor visit. However, many women will test positive for HPV who are not at high risk for cervical cancer. Therefore, additional ("triage") tests are needed to determine which women testing HPV-positive require additional... Read More
Gender:
FEMALE
Ages:
Between 30 years and 69 years
Trial Updated:
10/23/2023
Locations: Medical Faculty Associates, Washington, District of Columbia
Conditions: Human Papilloma Virus, Cervical Cancer, CIN 2/3
Register for Updates
Device Feasibility and Acceptability to Improve Insomnia in Cancer
NCT05875129
Recruiting
Sleep disruption is common among young adult cancer survivors for a variety of reasons. Cognitive behavioral therapy for insomnia (CBT-I) has been shown to improve chronic sleep disorders. This project will test the feasibility and acceptability of a new voice-activated virtual assistant (VAVA) device to deliver CBT-I to improve sleep among young adult cancer survivors with chronic sleep disorders.
Gender:
ALL
Ages:
Between 18 years and 39 years
Trial Updated:
10/04/2023
Locations: MedStar Washington Hospital Center, Washington, District of Columbia
Conditions: Cancer, Insomnia Chronic
Register for Updates
SPR PNS for Chronic Shoulder Pain
NCT05649917
Recruiting
The purpose of this research is to gather post-market data regarding the effectiveness of the SPRINT Peripheral Nerve Stimulation (PNS) System for the treatment of chronic shoulder pain due to chronic degenerative changes of your shoulder. The System delivers mild electrical stimulation to the muscles in your shoulder. The System includes up to two leads (small wires) that are placed through your skin into your shoulder. The leads attach to a device worn on your body that deliver stimulation (ca... Read More
Gender:
ALL
Ages:
Between 21 years and 100 years
Trial Updated:
09/26/2023
Locations: International Spine Pain & Performance Center, Washington, District of Columbia
Conditions: Shoulder Pain, Shoulder Injuries, Shoulder Arthritis
Register for Updates
Continuous Assessment of Hemodynamic Compensation in Pediatric Trauma Patients
NCT04911465
Recruiting
This is an observation study using the Flashback CRI T1 tablet to collect data on compensatory reserve index in pediatric trauma patients. Highest trauma activations at the institution will be enrolled in the study and data will be collected for 12-24 hours based on the patient's hemodynamic status. The device collects data via a pulse oximeter probe. No treatment decisions will be made based on the values of the on the CRI tablet. Data will be retrospectively reviewed to determine if any trends... Read More
Gender:
ALL
Ages:
Between 31 days and 26 years
Trial Updated:
09/25/2023
Locations: Children's National Hospital, Washington, District of Columbia
Conditions: Trauma
Register for Updates
SNS and PrEP Initiation and Adherence in Black SMM
NCT05499962
Recruiting
Specific Aim 1. Conduct 18 focus groups among Black gay, bisexual and other sexual minority men (SMM; n=72-90) in the Washington, DC area of different age groups (18-24, 25-34, 35+) and various pre-exposure prophylaxis (PrEP) use profiles (i.e., PrEP naïve, current PrEP users, and discontinued PrEP; two per age-group and PrEP use profile) to understand intervention feasibility, acceptability and appropriateness, how the intervention can address experienced and perceived socio-structural barriers... Read More
Gender:
MALE
Ages:
18 years and above
Trial Updated:
09/13/2023
Locations: Us Helping Us, People Into Living, Inc., Washington, District of Columbia
Conditions: HIV
Register for Updates
Group Visits for High Risk Type 1 Diabetes (T1D)
NCT05431686
Recruiting
The investigators propose to conduct a pilot prospective cohort study to assess the impact of shared medical appointments (SMA) visits in underserved youth with poorly controlled type 1 diabetes (T1D). The trial will employ an enrollment visit, SMA visits every 3 months over a 12 month study period, followed by a 6-month observational period to assess feasibility and acceptability of SMA and the impact on glycemic control, self-management skills, and health related quality of life.
Gender:
ALL
Ages:
8 years and above
Trial Updated:
08/31/2023
Locations: Children's National Hospital, Washington, District of Columbia
Conditions: Type 1 Diabetes
Register for Updates
AltaValve Early Feasibility Study Protocol
NCT03997305
Recruiting
Prospective, single-arm, multicenter study to evaluate the safety and performance of the AltaValve for the treatment of moderate to severe or severe mitral valve regurgitation in subjects who are considered high risk for mortality and morbidity from conventional open-heart surgery.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/31/2023
Locations: MedStar Washington Hospital, Washington, District of Columbia
Conditions: Mitral Regurgitation, Mitral Insufficiency, Mitral Valve Incompetence, Mitral Valve Regurgitation, Mitral Incompetence
Register for Updates
Transform CV Risk in Diabetes
NCT05948969
Recruiting
This initiative supports a real-world study of practice and physician prescribing patterns and a quality improvement initiative evaluating best practices (including clinical decision support, facilitated referral to cardiometabolic team-based care model, and general educational tools/resources) to im-prove use of guideline-directed therapeutics known to lower cardiovascular risk (CV) in patients with type 2 diabetes (T2D).
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/13/2023
Locations: Multiple sites nationwide, Washington, District of Columbia
Conditions: Type 2 Diabetes
Register for Updates
Diabetic Foot Ulcers-Comparing Transforming Powder to Standard of Care
NCT05046158
Recruiting
Phase IV, randomized, prospective, multi-center, open-label, comparison of transforming powder dressing to standard of care dressing for healing diabetic foot ulcers.
Gender:
ALL
Ages:
Between 18 years and 89 years
Trial Updated:
06/27/2023
Locations: MedStar Georgetown University Hospital, Washington, District of Columbia
Conditions: Diabetic Foot Ulcer
Register for Updates
Transcatheter Aortic Prosthesis Function: A Long-term Follow-up Study
NCT03002272
Recruiting
In this observational study, the investigators will enroll subjects who underwent TAVR or SAVR more than 3 years ago. Clinical and procedural data from the implant/surgery will be collected, alongside clinical and echocardiographic data from subsequent follow-up visits.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/25/2023
Locations: Washington Hospital Center, Washington, District of Columbia
Conditions: Aortic Valve Replacement
Register for Updates
Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Dementia With Lewy Bodies
NCT04002674
Recruiting
Dementia with Lewy Bodies (DLB) is an alphasynucleinopathy and the second most common form of dementia in the elderly. DLB shares striking neuropathological and clinical similarities with both Parkinson's disease (PD) and Alzheimer's disease (AD). Nilotinib (Tasigna®, AMN107, Novartis, Switzerland) is approved by the FDA and is well tolerated for CML treatment at oral doses of 600-800mg daily. The Investigators propose to perform a phase II randomized, double blinded, placebo controlled study to... Read More
Gender:
ALL
Ages:
Between 25 years and 90 years
Trial Updated:
05/11/2023
Locations: MedStar Georgetown University Hospital, Washington, District of Columbia
Conditions: Dementia With Lewy Bodies
Register for Updates